Spike-Specific Cd4 T-Cell Sars Test

T-cell Surface Glycoprotein CD4 (CD4) Antibody

abx231475-100ug 100 ug
EUR 610.8

Human IgG antibody Laboratories manufactures the spike-specific cd4 t-cell sars test reagents distributed by Genprice. The Spike-Specific Cd4 T-Cell Sars Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Spike-Specific products are available in stock. Specificity: Spike-Specific Category: Cd4 Group: T-Cell Sars

T-cell Surface Glycoprotein CD4 (CD4) Antibody

0.2 mg
EUR 886.8

T-cell Surface Glycoprotein CD4 (CD4) Antibody

  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

T-cell Surface Glycoprotein CD4 (CD4) Antibody

0.25 mg
EUR 710.4

T-cell Surface Glycoprotein CD4 (CD4) Antibody

0.25 mg
EUR 678

T-cell Surface Glycoprotein CD4 (CD4) Antibody

0.25 mg
EUR 678

T-cell Surface Glycoprotein CD4 (CD4) Antibody

1 mg
EUR 994.8

T-cell Surface Glycoprotein CD4 (CD4) Antibody

0.25 mg
EUR 678

T-Cell Sars information

SARS-CoV Spike Antibody

3221-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3221-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3223-002mg 0.02 mg
EUR 206.18
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3223-01mg 0.1 mg
EUR 523.7
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

anti- Kv1.4-Specific antibody

FNab04664 100µg
EUR 606.3
Description: Antibody raised against Kv1.4-Specific

anti- TUBB3 specific antibody

FNab09890 100µg
EUR 658.5
Description: Antibody raised against TUBB3 specific

anti- REDD1 specific antibody

FNab07228 100µg
EUR 658.5
Description: Antibody raised against REDD1 specific

anti- TDRKH specific antibody

FNab08580 100µg
EUR 658.5
Description: Antibody raised against TDRKH specific

SARS-CoV-2 Spike Peptide

9083P 0.05 mg
EUR 235.5
Description: (NT) SARS-CoV-2 Spike peptide

SARS-CoV-2 Spike Peptide

9087P 0.05 mg
EUR 235.5
Description: (CT) SARS-CoV-2 Spike RBD peptide

SARS-CoV-2 Spike Peptide

9091P 0.05 mg
EUR 235.5
Description: (IN) SARS-CoV-2 Spike peptide

SARS-CoV-2 Spike Peptide

9095P 0.05 mg
EUR 235.5
Description: (IN) SARS-CoV-2 Spike peptide

anti- SCN9A/Nav1.7-Specific antibody

FNab07646 100µg
EUR 702
Description: Antibody raised against SCN9A/Nav1.7-Specific

anti- Claudin 4-specific antibody

FNab01739 100µg
EUR 606.3
Description: Antibody raised against Claudin 4-specific

anti- Claudin 9-specific antibody

FNab01741 100µg
EUR 606.3
Description: Antibody raised against Claudin 9-specific

Human T- cell specific GTPase ELISA Kit

ELA-E1709h 96 Tests
EUR 988.8

Spike (SARS-CoV-2) Lentivirus

78010-1 100 µl
EUR 835
Description: Cell entry of SARS-CoV-2 depends on the binding of viral spike protein to cellular receptor ACE2. The SARS-CoV-2 Spike Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. The particles contain the full length SARS-CoV-2 spike gene (QHD43416.1) driven by an EF1a promoter._x000D_